Tag Archives: Barriers

Barriers to HCV treatment access from the drug user's point of view: stigma, complex lives and damaged veins

Being asymptomatic led people to ignore their diagnosis and not to engage with medical care for hepatitis C, and interviewees said that they received little information about the impact of hepatitis C on their health or the likely progression of liver disease. People deferred treatment for a long time due to lack of symptoms, but… Read More »

Specialty Generics: Barriers To Uptake

Earlier this year, Teva Pharmaceutical Industries Ltd., the world’s largest generic drugmaker, laid off thousands of workers as part of a global restructuring.(AP Photo/Tsafrir Abayov) Since enactment of the 1984 Hatch-Waxman Act, generic drug uptake in the U.S. has increased dramatically. At present, nearly 90% of prescriptions in the U.S. are generic drugs, compared with… Read More »